Clinical Investigation Centre, INSERM, Rennes, France.
University of Rennes 1, Rennes, France.
Vasc Med. 2020 Aug;25(4):354-363. doi: 10.1177/1358863X20902272. Epub 2020 Apr 17.
Lower extremity peripheral artery disease (PAD) induces an ischemic pain in the lower limbs and leads to walking impairment. Electrical stimulation has been used in patients with PAD, but no systematic review has been proposed to address the efficacy of the technique as a treatment for walking impairment in PAD. A systematic search was performed to identify trials focused on electrical stimulation for the treatment of walking impairment in patients with PAD in the Cochrane Central Register, PubMed, Embase, and the Web of Science. Studies were included where the primary outcomes were pain-free walking distance and/or maximal walking distance. When appropriate, eligible studies were independently assessed for quality using the Cochrane Collaboration's tool for assessing risk of bias. Five studies eligible for inclusion were identified, of which only two were randomized controlled studies. Trial heterogeneity prevented the use of the GRADE system and the implementation of a meta-analysis. Three types of electrical stimulation have been used: neuromuscular electrical stimulation (NMES, = 3), transcutaneous electrical stimulation ( = 1), and functional electrical stimulation ( = 1). The two available randomized controlled studies reported a significant improvement in maximal walking distance (+40 m/+34% and +39 m/+35%, respectively) following a program of NMES. Owing to the low number of eligible studies, small sample size, and the risk of bias, no clear clinical indication can be drawn regarding the efficacy of electrical stimulation for the management of impaired walking function in patients with PAD. Future high-quality studies are required to define objectively the effect of electrical stimulation on walking capacity.
下肢外周动脉疾病(PAD)会引起下肢缺血性疼痛,并导致行走功能障碍。电刺激已被用于 PAD 患者,但尚未提出系统评价来评估该技术作为治疗 PAD 患者行走功能障碍的疗效。系统检索了 Cochrane 中央注册库、PubMed、Embase 和 Web of Science 中关于电刺激治疗 PAD 患者行走功能障碍的试验。主要结局为无痛行走距离和/或最大行走距离的研究被纳入。在适当的情况下,使用 Cochrane 协作组评估偏倚风险的工具独立评估合格研究的质量。确定了 5 项符合纳入标准的研究,其中只有 2 项为随机对照研究。试验异质性阻止了 GRADE 系统的使用和荟萃分析的实施。已使用了三种类型的电刺激:神经肌肉电刺激(NMES, = 3)、经皮电刺激( = 1)和功能性电刺激( = 1)。两项可用的随机对照研究报告了 NMES 方案后最大行走距离的显著改善(分别增加 40 米/增加 34%和增加 39 米/增加 35%)。由于合格研究数量少、样本量小以及存在偏倚风险,无法就电刺激治疗 PAD 患者行走功能障碍的疗效得出明确的临床结论。需要未来开展高质量的研究来客观确定电刺激对行走能力的影响。